Literature DB >> 20692319

CC-chemokine MIP-1α in the spinal cord contributes to nerve injury-induced neuropathic pain.

Norikazu Kiguchi1, Yuka Kobayashi, Takehiko Maeda, Fumihiro Saika, Shiroh Kishioka.   

Abstract

We investigated the involvement of spinal macrophage inflammatory protein-1α (MIP-1α), an inflammatory chemokine, in partial sciatic nerve ligation (PSL)-induced neuropathic pain in mice. PSL increased MIP-1α mRNA levels as well as levels of the MIP-1α receptor, CCR1, but not CCR5 in the spinal dorsal horn. PSL-induced tactile allodynia and thermal hyperalgesia were prevented by intrathecal (i.t.) injection of a neutralizing antibody of MIP-1α (2ng). Recombinant MIP-1α (10pmol, i.t.) elicited long-lasting tactile allodynia and thermal hyperalgesia in naïve mice. These results suggest that peripheral nerve injury elicits the up-regulation of spinal MIP-1α and CCR1 to participate in neuropathic pain. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20692319     DOI: 10.1016/j.neulet.2010.07.085

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  21 in total

1.  Anti-nociceptive Role of CXCL1 in a Murine Model of Peripheral Nerve Injury-induced Neuropathic Pain.

Authors:  Ling Cao; Jennifer T Malon
Journal:  Neuroscience       Date:  2018-01-06       Impact factor: 3.590

2.  Experimental autoimmune prostatitis induces microglial activation in the spinal cord.

Authors:  Larry Wong; Joseph D Done; Anthony J Schaeffer; Praveen Thumbikat
Journal:  Prostate       Date:  2014-09-27       Impact factor: 4.104

3.  The three isoforms of nitric oxide synthase distinctively affect mouse nocifensive behavior.

Authors:  Julia Finkel; Virginia Guptill; Alfia Khaibullina; Nicholas Spornick; Olavo Vasconcelos; David J Liewehr; Seth M Steinberg; Zenaide M N Quezado
Journal:  Nitric Oxide       Date:  2011-12-17       Impact factor: 4.427

4.  Role of lipocalin-2-chemokine axis in the development of neuropathic pain following peripheral nerve injury.

Authors:  Sangmin Jeon; Mithilesh Kumar Jha; Jiyeon Ock; Jungwan Seo; Myungwon Jin; Heejung Cho; Won-Ha Lee; Kyoungho Suk
Journal:  J Biol Chem       Date:  2013-07-08       Impact factor: 5.157

5.  The blockade of CC chemokine receptor type 1 influences the level of nociceptive factors and enhances opioid analgesic potency in a rat model of neuropathic pain.

Authors:  Katarzyna Pawlik; Anna Piotrowska; Klaudia Kwiatkowski; Katarzyna Ciapała; Katarzyna Popiolek-Barczyk; Wioletta Makuch; Joanna Mika
Journal:  Immunology       Date:  2020-02-05       Impact factor: 7.397

Review 6.  Chemokines in neuron-glial cell interaction and pathogenesis of neuropathic pain.

Authors:  Zhi-Jun Zhang; Bao-Chun Jiang; Yong-Jing Gao
Journal:  Cell Mol Life Sci       Date:  2017-04-07       Impact factor: 9.261

7.  Vimentin Promotes Astrocyte Activation After Chronic Constriction Injury.

Authors:  Pengfei Xue; Liming Chen; Xiongsong Lu; Jinlong Zhang; Guofeng Bao; Guanhua Xu; Yuyu Sun; Xiaofeng Guo; Jiawei Jiang; Haiyan Gu; Zhiming Cui
Journal:  J Mol Neurosci       Date:  2017-08-08       Impact factor: 3.444

8.  Altered expression of glial markers, chemokines, and opioid receptors in the spinal cord of type 2 diabetic monkeys.

Authors:  Norikazu Kiguchi; Huiping Ding; Christopher M Peters; Nancy D Kock; Shiroh Kishioka; J Mark Cline; Janice D Wagner; Mei-Chuan Ko
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-10-14       Impact factor: 5.187

9.  CCR5 blockade promotes M2 macrophage activation and improves locomotor recovery after spinal cord injury in mice.

Authors:  Fengtao Li; Bin Cheng; Jian Cheng; Dong Wang; Haopeng Li; Xijing He
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

10.  Resident Macrophages in Muscle Contribute to Development of Hyperalgesia in a Mouse Model of Noninflammatory Muscle Pain.

Authors:  Wei-Yi Gong; Ramy E Abdelhamid; Carolina S Carvalho; Kathleen A Sluka
Journal:  J Pain       Date:  2016-07-01       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.